|
2021
|
Invention
|
Th17 differentiation markers for acne and uses thereof.
A method is described for using IL-12Rβ1... |
|
|
Invention
|
Novel biaromatic propynyl compounds, pharmaceutical and cosmetic compositions containing same, an... |
|
|
Invention
|
Pharmaceutical composition in the form of a water-in-oil emulsion (w/o) and its uses.
The invent... |
|
2020
|
Invention
|
Pulse photodynamic treatment of photodamaged skin. The present invention is related to a pulse ph... |
|
|
Invention
|
Method for determining release rates of active principle ingredients from at least one semisolid ... |
|
|
Invention
|
Trpa1 antagonists for use in the treatment of atopic dermatitis.
The present invention relates t... |
|
|
Invention
|
Mtor inhibitor compounds. The invention relates to novel mTOR inhibitor compounds having the gene... |
|
|
Invention
|
Substituted pyrazolo[3,4-d]pyrimidines as mtor inhibitors. The invention relates to novel mTOR in... |
|
2019
|
Invention
|
Pharmaceutical composition comprising brimonidine, and uses thereof. The invention relates to a p... |
|
|
Invention
|
Pharmaceutical composition in the form of a water-in-oil emulsion (w/o) and its uses. The inventi... |
|
|
Invention
|
Chemokine cxcr1 and cxcr2 receptor antagonist compounds, and use thereof in the treatment of chem... |
|
|
Invention
|
Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (r... |
|
|
Invention
|
Pulse photodynamic treatment of acne.
A pulse photodynamic therapy (or pulse PDT) treatment of a... |
|
2018
|
Invention
|
Novel mtor inhibitor compounds. The invention relates to novel mTOR inhibitor compounds. The inve... |
|
|
Invention
|
Mtor inhibitor compounds. The invention relates to novel mTOR inhibitor compounds. The invention ... |
|
|
Invention
|
Novel mtor inhibitor coumponds. The invention relates to novel mTOR inhibitor compounds. The inve... |
|
|
Invention
|
Uv device for evaluation of skin conditions. A lighting and filtering device configured for use w... |
|
|
Invention
|
Specific acetyl-coa carboxylase inhibitors for use in the treatment and/or prevention of acne. Th... |
|
|
Invention
|
Kit for use in preventing and/or treating side effects related to an anti-cancer therapy. The inv... |
|
|
Invention
|
Method for the generation of a skin organoculture model and skin model. The present invention rel... |
|
|
Invention
|
Model for evaluation of dermal fillers. ex vivo ex vivo human skin and coupled with injection of ... |
|
|
Invention
|
System for assisting in the repositioning of at least one dermatological monitoring zone, associa... |
|
|
Invention
|
Vegf inhibitors for use for preventing and/or treating acne. The present invention relates to the... |
|
|
Invention
|
Device for packaging and dispensing a product, notably a pharmaceutical or cosmetic product. The ... |
|
|
Invention
|
Cream gels comprising at least one retinoid and benzoyl peroxide. Stable cream gel dermatological... |
|
|
Invention
|
Device and method for measuring diffusion of a compound across a membrane. Device (10) for measur... |
|
|
Invention
|
Pzrayole derivatives used as inverse agonists of the ror gamma (t) retinoid-related orphan gamma ... |
|
|
Invention
|
Hydroxylated sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamm... |
|
2017
|
Invention
|
Method for treating scars with adapalene 0.3%.
A method is described for treating a scar with an... |
|
|
Invention
|
Method of crosslinking glycosaminoglycans.
A new hydrogel made of crosslinked glycosaminoglycans... |
|
|
Invention
|
Method of crosslinking glycosaminoglycans.
A new hydrogel made of double crosslinked glycosamino... |
|
|
Invention
|
Method of crosslinking glycosaminoglycans. A new hydrogel made of crosslinked glycosaminoglycans,... |
|
|
Invention
|
Device for packaging and dispensing a product, notably a cosmetic product. The device for packagi... |
|
|
Invention
|
Biaromatic propynyl compounds, pharmaceutical and cosmetic compositions containing same, and uses... |
|
|
Invention
|
Nlrp3 inhibitors for the treatment of inflammatory skin disorders. The use of an NLRP3 inhibitor ... |
|
2016
|
Invention
|
Method for synthesizing enantiomerically pure n-(pyridin-4-yl)-2-hydroxy-alkylamide derivatives. ... |
|
|
Invention
|
Composition containing lactic acid bacteria and its use to treat atopic dermatitis. Lactobacillus... |
|
|
Invention
|
Diffusion cell and uses for evaluating the diffusion of a compound through a membrane. A diffusio... |
|
|
Invention
|
No-rinse chemical foam comprising ivermectin. A self-foaming composition is described that includ... |
|
|
Invention
|
No-rinse chemical foam containing brimonidine, and use thereof in the treatment of rosacea. A sel... |
|
|
Invention
|
Rinse-off self-foaming cleansing composition containing ivermectin.
A self-foaming composition i... |
|
|
Invention
|
No-rinse chemical foam containing trifarotene, and use thereof in the treatment of ichthyosis. A ... |
|
|
Invention
|
Self-foaming cleansing composition containing clobetasol propionate, and use thereof in the treat... |
|
|
Invention
|
No-rinse chemical foam containing trifarotene, and use thereof in the treatment of acne. A self-f... |
|
|
Invention
|
No-rinse chemical foam containing clobetasol propionate, and use thereof in the treatment of psor... |
|
2015
|
Invention
|
Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gam... |
|
|
Invention
|
Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan recept... |
